Company plans to uplist to the Nasdaq Capital MarketLONDON and PHOENIX, March 04, 2022 AccuStem Sciences, Inc. , a life sciences company dedicated to improving outcomes for patients with cancer,. | March 4, 2022
Company plans to uplist to the Nasdaq Capital MarketLONDON and PHOENIX, March 04, 2022 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTC PINK: ACUT), a life sciences company dedicated to improving outcomes